-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Synthetic Genomics partners with ExxonMobil to develop algae biofuels
Synthetic Genomics (SGI) and ExxonMobil signed a new research agreement to jointly fund the development of algal biofuels
.
Back in June 2009, Synthetic Genomics and ExxonMobil formed a research and development consortium focused on natural and conventionally modified algae strains
.
The two companies have been working together for almost four years now and have gained considerable knowledge
in developing economical and scalable algal biofuels.
The new agreement is a fundamental scientific research initiative that will focus on developing improved algae strains that can significantly increase yields, and developing biofuels
using synthetic genomics science and technology.
Building on previous collaborative research, the agreement will place greater emphasis on developing basic scientific research on strains that allow them to multiply rapidly and produce a high proportion of oil
.
Synthetic Genomics has made significant progress
in understanding algae genetics, growth characteristics, and improving algal biomass and oil productivity.
For the signing of the new agreement, Synthetic Genomics said that it will give full play to the company's core advantages in the field of synthetic biology and help the company develop better algae strains
.
(Bo Zhang)